QVMS Among Small Cap ETFs
End-of-day Nov 16, 2026 · 97 Small cap ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −1.9% | +2.4% | −5.3% | +17.3% | +20.8% | +61.8% | +30.9% | +41.1% |
| Peer average | −1.2% | −2.1% | +1.3% | −5.3% | +14.8% | +18.8% | +63.0% | +27.5% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$7 of every $1,000 in QVMS is Paycom
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | PAYCPaycom Software | Technology | 0.74% | $73.71 | 7,163 | $1.8M |
| 2 | RHPRyman Hospitality Properties | Real Estate | 0.61% | $61.40 | 11K | $1.5M |
| 3 | VSXYVictoria's Secret | Consumer Cyclical | 0.61% | $61.23 | 14K | $1.5M |
| 4 | JXNJackson Financial | Financial Services | 0.60% | $60.31 | 10K | $1.5M |
| 5 | LWLamb Weston | Consumer Defensive | 0.56% | $56.46 | 24K | $1.4M |
| 6 | EPAMEPAM Systems | Technology | 0.56% | $56.39 | 8,359 | $1.4M |
| 7 | VSATViasat | Technology | 0.55% | $55.05 | 20K | $1.3M |
| 8 | TGTXTG Therapeutics | Healthcare | 0.54% | $54.40 | 20K | $1.3M |
| 9 | ALKSAlkermes | Healthcare | 0.52% | $52.24 | 27K | $1.3M |
| 10 | PTGXProtagonist Therapeutics | Healthcare | 0.52% | $51.91 | 9,586 | $1.3M |
| 11 | EMNEastman Chemical | Basic Materials | 0.51% | $50.75 | 19K | $1.2M |
| 12 | AWIArmstrong World Industries | Basic Materials | 0.50% | $49.85 | 6,860 | $1.2M |
| 13 | KMXCarMax | Consumer Cyclical | 0.49% | $49.47 | 22K | $1.2M |
| 14 | MHKMohawk Industries | Consumer Cyclical | 0.49% | $48.71 | 7,992 | $1.2M |
| 15 | ESIElement Solutions | Basic Materials | 0.48% | $48.45 | 35K | $1.2M |
of the $584B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | PAYC | Paycom Software | 0.74% |
| 2 | RHP | Ryman Hospitality Properties | 0.61% |
| 3 | VSXY | Victoria's Secret & | 0.61% |
| 4 | JXN | Jackson Financial | 0.60% |
| 5 | LW | Lamb Weston | 0.56% |
| 6 | EPAM | EPAM Systems | 0.56% |
| 7 | VSAT | Viasat | 0.55% |
| 8 | TGTX | TG Therapeutics | 0.54% |
| 9 | ALKS | Alkermes | 0.52% |
| 10 | PTGX | Protagonist Therapeutics | 0.52% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.13 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0935 |
| Mar 23, 2026 | Mar 27, 2026 | $0.11 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0886 |
| Sep 22, 2025 | Sep 26, 2025 | $0.10 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0688 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0488 |
| Dec 23, 2024 | Dec 27, 2024 | $0.15 |
| Sep 23, 2024 | Sep 27, 2024 | $0.10 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0756 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0883 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0857 |